American Century Companies Inc Intra Cellular Therapies, Inc. Transaction History
American Century Companies Inc
- $168 Billion
- Q4 2024
A detailed history of American Century Companies Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 314,362 shares of ITCI stock, worth $41.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
314,362
Previous 250,939
25.27%
Holding current value
$41.3 Million
Previous $18.3 Million
43.09%
% of portfolio
0.02%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding ITCI
# of Institutions
419Shares Held
88.8MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.28 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$831 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$674 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$427 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$422 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...